The investor has nominated Suresh Katta, founder and CEO of clinical analytics company Saama, and Venkat Peri, CEO of ...

In a letter seen by MarketWatch, the activist fund blamed the sharp drop in Novavax’s sales on the U.S. vaccine-maker’s ...

The U.S. Food and Drug Administration approved the use of Novavax’s COVID-19 vaccine in 2022.The activist hedge fund Shah ...

Novavax has undertaken successive lay-off rounds as part of a $1.1bn cost cutting drive to stave off bankruptcy after it ...

Two Christian health-care workers in Virginia lost their claims that Inova Health Systems’ denial of their requests for ...

A top shareholder of COVID-19 vaccine maker Novavax on Monday said the company has been badly mismanaged and nominated two candidates to serve on Novavax's board.

Discover how Novavax Inc's patent for coronavirus Spike proteins & nanoparticles in vaccines enhances immunogenicity & protects against SARS-CoV-2.

In just the past 12 months, Novavax ( NVAX 0.94%) stock has plummeted 48% in value. The once-promising COVID vaccine maker ...

Shah Capital on Monday called for "an urgent shake up" of the Board of Directors of Novavax (Nasdaq: NVAX) in a letter to the Maryland-based biotechnology company. The investment firm, which is ...

In an open letter, the hedge fund accuses Novavax’s leadership of squandering its “many significant competitive advantages ...

Believes the two new nominated directors possess the necessary experience to tackle the underperformance of the business ...